Company Overview and News

 
Stock Investors May Have Missed the Boat on Australia’s Rally - Bloomberg

2018-05-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
The Commonwealth Bank At Attractive Levels

2018-03-12 seekingalpha
The Commonwealth Bank's stock price has fallen on the back of several scandals, including breaches of anti-money laundering laws.

 
National Australia Bank: The Most Attractive Aussie Bank

2018-02-06 seekingalpha
With a dividend yield of 6.7% and a P/E ratio of 13.4, it presents the best buy out of the Australian banks.

 
Genworth Mortgage Insurance Australia, A Long Term Buy

2018-01-31 seekingalpha
Genworth Mortgage Insurance provides a fantastic dividend yield (expected to be maintained at ~9% of todays price).

 
Genworth: Additional Thoughts On Plan-B And Valuation

2018-01-12 seekingalpha
This is a Follow-On Piece to Our Prior Article Regarding Genworth's Plan B Options if the China Oceanwide Merger is Blocked by Regulators.

 
Markets Live: ASX set for downbeat end to week

2017-12-15 theage.com.au
A relatively upbeat week for the ASX ended on a sour note on Friday, as banks capped a tough week with more losses.

 
Markets Live: ASX set for downbeat end to week

2017-12-15 smh.com.au
A relatively upbeat week for the ASX ended on a sour note on Friday, as banks capped a tough week with more losses.

 
Genworth Financial: Heads I Win, Tails I Win More

2017-08-03 seekingalpha
Earnings improvement during the last two quarters suggests the stock is worth more than the buyout price.

 
Genworth Financial Announces Second Quarter 2017 Results

2017-08-01 prnewswire
Net Income Of $202 Million, Up 17 Percent Compared To Prior Year; Adjusted Operating Income Of $151 Million, Up 23 Percent Compared To Prior Year

 
Genworth Financial to Issue 2nd Quarter 2017 Results on August 1, 2017

2017-07-19 prnewswire
RICHMOND, Va., July 19, 2017 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) today announced it would issue its earnings release containing second quarter results after the market closes on August 1, 2017; the earnings release and quarterly financial supplement will be available through the company's website, http://investor.genworth.com at the time of their release to the public. Due to the pending sale to China Oceanwide, the company does not plan to host an earnings call.

 
Genworth Honored with Texas MBA Pinnacle Award

2017-05-30 prnewswire
RICHMOND, Va., May 30, 2017 /PRNewswire/ -- Genworth Mortgage Insurance, an operating segment of Genworth Financial, Inc. (NYSE: GNW), was presented with the Texas Mortgage Bankers Association's ("TMBA") 2016 Pinnacle Award at the TMBA's 101st Annual Convention on May 23. The award honored the 10 TMBA member companies who have most supported the association through leadership, participation, and program contributions.

 
Genworth Financial - Where Else Can You Make More Than 50% In Less Than 6 Months?

2017-02-13 seekingalpha
The value of GNW’s ownership in two publicly held companies is $5.40 and the deal is only $5.43.

 
Earnings season may challenge Trump reflation trade

2017-02-12 theage.com.au
Despite the overarching global narrative of a return to growth and inflation, this reporting season may show that life among many listed Australian businesses remains a slog.

 
Earnings season may challenge Trump reflation trade

2017-02-12 smh.com.au
Despite the overarching global narrative of a return to growth and inflation, this reporting season may show that life among many listed Australian businesses remains a slog.

 
Trump bumps ASX through 5700 to cap solid week

2017-02-10 theage.com.au
Investors poured into shares on Friday, buoyed by more of US President Donald Trump's promises to introduce "phenomenal" tax cuts, while local investors digested a string of profit results this week as earnings season heated up.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...